iSBTc Active Committees for 2010

Development Committee

The Development Committee is responsible for proposing and carrying out fundraising activities in support of the Society and its objectives. This Committee maintains all sponsor information and directs the assignment of Society members to solicit potential sponsors based on his or her professional contacts and/or area of expertise. This Committee determines which sponsors should be targeted for funding of certain programs and assists Society members in tailoring their approach to sponsors. This Committee develops strategies to achieve those goals set by the President and Committee members as well as those that enhance the Society's profitability in pursuit of such goals.

Co-Chairs

Howard L. Kaufman, MD
Rush University Medical Center

Arnold H. Zea, PhD
LSU Health Sciences Center

Members

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center

Pierre Coulie, MD, PhD
De Duve Institute
University of Louvain

Glenn Dranoff, MD
Dana-Farber Cancer Institute

Thomas Gajewski, MD, PhD
University of Chicago

Kristen Hege, MD
University of California, San Francisco

Patrick Hwu, MD
MD Anderson Cancer Center

Elizabeth Jaffee, MD
Johns Hopkins University

Pawel Kalinski, MD, PhD
University of Pittsburgh

Koji Kawakami, MD, PhD
Kyoto University

Julian Kim, MD
Case Comprehensive Cancer Center

John M. Kirkwood, MD
University of Pittsburgh

Thomas Kleen, PhD
Cellular Technology Ltd.

Kim Margolin, MD
Seattle Cancer Care Alliance

Francesco Marincola, MD
National Institutes of Health

Ira Mellman, PhD
Genentech

William J. Murphy, PhD
University of California, Davis

Anthony Ribas, MD
UCLA Medical Center

Senthamil Selvan, PhD
National University

Vernon Sondak, MD
H. Lee Moffitt Cancer Center

Wenru Song, MD, PhD
Pfizer

Walter Urba, MD, PhD
Earle A. Chiles Research Institute

George Weiner, MD
University of Iowa

Jon Wigginton, MD
Bristol-Myers Squibb